dr. voss discusses neoadjuvant trials of immunotherapy in rcc
Published 6 years ago • 103 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:15
dr. voss on treatment in the neoadjuvant setting for kidney cancer
-
1:06
dr. voss on the future of clinical trials for kidney cancer
-
1:02
dr. voss on the case for neoadjuvant treatment in kidney cancer
-
1:47
dr. zhang discusses neoadjuvant therapy in kidney cancer
-
2:14
dr. voss on bevacizumab with crlx101 in advanced rcc
-
4:14
neoadjuvant approaches in rcc
-
1:32
dr. voss on phase i/ii trial data of medi0680/durvalumab versus nivolumab in mrcc
-
1:02
dr. gupta discusses combination immunotherapy in rcc
-
1:51
dr. choueiri on ongoing trials of immunotherapy in rcc
-
2:21
dr. voss on combining dalantercept and axitinib for advanced kidney cancer
-
1:13
addressing concerns for neoadjuvant therapies in locally advanced kidney cancer
-
1:30
dr. nanus on ongoing studies in the neoadjuvant setting for rcc
-
1:47
dr. choueiri discusses immunotherapy in rcc
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
8:43
immunotherapy in renal cell carcinoma
-
39:34
immunotherapy in renal cell carcinoma
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
1:01
dr. nanus on trials investigating immunotherapy in rcc
-
6:57
dosing schedule of sunitinib in renal cell carcinoma